Browsing by Subject "PCSK9"
Now showing items 1-1 of 1
-
Cost Effectiveness of PCSK9 Inhibitors for the Secondary Prevention of Cardiovascular Disease in Ireland: Considerations given to Population Heterogeneity
(Trinity College Dublin. School of Medicine. Discipline of Pharmacology & Therapeutics, 2020)The aim of this thesis was to evaluate the cost-effectiveness of PCSK9 inhibitors (alirocumab and evolocumab for the secondary prevention of CVD (cardiovascular disease) in Ireland. Also, to identify the subgroups of this ...